Neurotrophins, endocannabinoids and thermo-transient receptor potential: A threesome in pain signalling

European Journal of Neuroscience

Volumn 39, Issue 3, 2014, Pages 353-362

  Devesa, Isabel ^a   Ferrer Montiel, Antonio ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Allodynia; Desensitisation; Excitability; Exocytosis; Hyperalgesia; Nociceptor

Indexed keywords

ARTEMIN; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; METABOTROPIC RECEPTOR; NEUROTROPHIN; PROSTANOID; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1;

ARTICLE; CELL HETEROGENEITY; CHRONIC PAIN; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; OXIDATIVE STRESS; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ALLODYNIA; DESENSITISATION; EXCITABILITY; EXOCYTOSIS; HYPERALGESIA; NOCICEPTOR;

ANIMALS; ENDOCANNABINOIDS; HUMANS; NERVE GROWTH FACTORS; NEURALGIA; SIGNAL TRANSDUCTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84893345478     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12455     Document Type: Article

References (147)

1. Adler, J.E., Nico, L., VandeVord, P. & Skoff, A.M. (2009) Modulation of neuropathic pain by a glial-derived factor. Pain Med., 10, 1229-1236.
2. Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C.E., Brenner, G.J., Rubino, T., Michalski, C.W., Marsicano, G., Monory, K., Mackie, K., Marian, C., Batkai, S., Parolaro, D., Fischer, M.J., Reeh, P., Kunos, G., Kress, M., Lutz, B., Woolf, C.J. & Kuner, R. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci., 10, 870-879.
3. Akbar, A., Yiangou, Y., Facer, P., Walters, J.R., Anand, P. & Ghosh, S. (2008) Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut, 57, 923-929.
4. Akopian, A.N., Ruparel, N.B., Patwardhan, A. & Hargreaves, K.M. (2008) Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J. Neurosci., 28, 1064-1075.
5. Akopian, A.N., Ruparel, N.B., Jeske, N.A., Patwardhan, A. & Hargreaves, K.M. (2009) Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol. Sci., 30, 79-84.
6. Albers, K.M., Woodbury, C.J., Ritter, A.M., Davis, B.M. & Koerber, H.R. (2006) Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J. Neurosci., 26, 2981-2990.
7. Allen, S.J. & Dawbarn, D. (2006) Clinical relevance of the neurotrophins and their receptors. Clin. Sci., 110, 175-191.
8. Alvarez, P., Chen, X., Bogen, O., Green, P.G. & Levine, J.D. (2012) IB4(+) nociceptors mediate persistent muscle pain induced by GDNF. J. Neurophysiol., 108, 2545-2553.
9. Amaya, F., Shimosato, G., Nagano, M., Ueda, M., Hashimoto, S., Tanaka, Y., Suzuki, H. & Tanaka, M. (2004) NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur. J. Neurosci., 20, 2303-2310.
10. Anand, P. (2004) Neurotrophic factors and their receptors in human sensory neuropathies. Prog. Brain Res., 146, 477-492.
11. Anand, U., Otto, W.R., Facer, P., Zebda, N., Selmer, I., Gunthorpe, M.J., Chessell, I.P., Sinisi, M., Birch, R. & Anand, P. (2008) TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci. Lett., 438, 221-227.
12. Andersson, D.A., Gentry, C., Alenmyr, L., Killander, D., Lewis, S.E., Andersson, A., Bucher, B., Galzi, J.L., Sterner, O., Bevan, S., Högestätt, E.D. & Zygmunt, P.M. (2011) TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nat. Commun., 2, 551.
13. Andres, C., Meyer, S., Dina, O.A., Levine, J.D. & Hucho, T. (2010) Quantitative automated microscopy (QuAM) elucidates growth factor specific signalling in pain sensitization. Mol. Pain, 6, 98.
14. Andres, C., Hasenauer, J., Allgower, F. & Hucho, T. (2012) Threshold-free population analysis identifies larger DRG neurons to respond stronger to NGF stimulation. PLoS ONE, 7, e34257.
15. Asano, K., Asahina, S., Sakai, M., Matsuda, T., Ou, K., Maeda, Y. & Hisamitsu, T. (2006) Attenuating effect of artemin on herpes-related pain responses in mice infected with herpes simplex. In Vivo, 20, 533-537.
16. Barabas, M.E., Kossyreva, E.A. & Stucky, C.L. (2012) TRPA1 is functionally expressed primarily by IB4-binding, non-peptidergic mouse and rat sensory neurons. PLoS ONE, 7, e47988.
17. Basbaum, A.I., Bautista, D.M., Scherrer, G. & Julius, D. (2009) Cellular and molecular mechanisms of pain. Cell, 139, 267-284.
18. Belghiti, M., Estévez-Herrera, J., Giménez-Garzó, C., González-Usano, A., Montoliu, C., Ferrer-Montiel, A., Felipo, V. & Planells-Cases, R. (2013) Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease. J. Biol. Chem., 288, 9675-9685.
19. Belmonte, C. & Viana, F. (2008) Molecular and cellular limits to somatosensory specificity. Mol. Pain, 4, 14.
20. Bespalov, M.M. & Saarma, M. (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci., 28, 68-74.
21. Bespalov, M.M., Sidorova, Y.A., Tumova, S., Ahonen-Bishopp, A., Magalhães, A.C., Kulesskiy, E., Paveliev, M., Rivera, C., Rauvala, H. & Saarma, M. (2011) Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol., 192, 153-169.
22. Bíró, T., Tóth, B.I., Haskó, G., Paus, R. & Pacher, P. (2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol. Sci., 30, 411-420.
23. Bogen, O., Joseph, E.K., Chen, X. & Levine, J.D. (2008) GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican. Eur. J. Neurosci., 28, 12-19.
24. Brederson, J.D., Kym, P.R. & Szallasi, A. (2013) Targeting TRP channels for pain relief. Eur. J. Pharmacol., 716, 61-76.
25. Camprubi-Robles, M., Planells-Cases, R. & Ferrer-Montiel, A. (2009) Differential contribution of SNARE-dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors. FASEB J., 23, 3722-3733.
26. Cavanaugh, D.J., Chesler, A.T., Bráz, J.M., Shah, N.M., Julius, D. & Basbaum, A.I. (2011) Restriction of transient receptor potential vanilloid-1 to the peptidergic subset of primary afferent neurons follows its developmental downregulation in nonpeptidergic neurons. J. Neurosci., 31, 10119-10127.
27. Ceyhan, G.O., Schäfer, K.H., Kerscher, A.G., Rauch, U., Demir, I.E., Kadihasanoglu, M., Böhm, C., Müller, M.W., Büchler, M.W., Giese, N.A., Erkan, M. & Friess, H. (2010) Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann. Surg., 251, 923-931.
28. Chan, C.L., Facer, P., Davis, J.B., Smith, G.D., Egerton, J., Bountra, C., Williams, N.S. & Anand, P. (2003) Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet, 361, 385-391.
29. Chiu, I.M., von Hehn, C.A. & Woolf, C.J. (2012) Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci., 15, 1063-1067.
30. Clapham, D.E., Julius, D., Montell, C. & Schultz, G. (2005) International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels. Pharmacol. Rev., 57, 427-450.
31. Clapper, J.R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N.R., Spradley, J.M., Hohmann, A.G., Calignano, A., Mor, M., Tarzia, G. & Piomelli, D. (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat. Neurosci., 13, 1265-1270.
32. Cortright, D.N. & Szallasi, A. (2009) TRP channels and pain. Curr. Pharm. Design, 15, 1736-1749.
33. De Petrocellis, L. & Di Marzo, V. (2009) Role of endocannabinoids and endovanilloids in Ca2 + signalling. Cell Calcium, 45, 611-624.
34. Di Marzo, V. (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov., 7, 438-455.
35. Diogenes, A., Akopian, A.N. & Hargreaves, K.M. (2007) NGF up-regulates TRPA1: implications for orofacial pain. J. Dent. Res., 86, 550-555.
36. Dubin, A.E. & Patapoutian, A. (2010) Nociceptors: the sensors of the pain pathway. J. Clin. Invest., 120, 3760-3772.
37. Elitt, C.M., McIlwrath, S.L., Lawson, J.J., Malin, S.A., Molliver, D.C., Cornuet, P.K., Koerber, H.R., Davis, B.M. & Albers, K.M. (2006) Artemin overexpression in skin enhances expression of TRPV1 and TRPA1 in cutaneous sensory neurons and leads to behavioral sensitivity to heat and cold. J. Neurosci., 26, 8578-8587.
38. Elitt, C.M., Malin, S.A., Koerber, H.R., Davis, B.M. & Albers, K.M. (2008) Overexpression of artemin in the tongue increases expression of TRPV1 and TRPA1 in trigeminal afferents and causes oral sensitivity to capsaicin and mustard oil. Brain Res., 1230, 80-90.
39. Engel, M.A., Izydorczyk, I., Mueller-Tribbensee, S.M., Becker, C., Neurath, M.F. & Reeh, P.W. (2011) Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin. Neuropeptides, 45, 229-237.
40. Evans, R.M., Scott, R.H. & Ross, R.A. (2007) Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. Brit. J. Pharmacol., 152, 404-413.
41. Facer, P., Casula, M.A., Smith, G.D., Benham, C.D., Chessell, I.P., Bountra, C., Sinisi, M., Birch, R. & Anand, P. (2007) Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol., 7, 11.
42. Ferrer-Montiel, A., Fernández-Carvajal, A., Planells-Cases, R., Fernández-Ballester, G., González-Ros, J.M., Messeguer, A. & González-Muñiz, R. (2012) Advances in modulating thermosensory TRP channels. Expert Opin. Ther. Pat., 22, 999-1017.
43. Fioravanti, B., De Felice, M., Stucky, C.L., Medler, K.A., Luo, M.C., Gardell, L.R., Ibrahim, M., Malan, T.P. Jr, Yamamura, H.I., Ossipov, M.H., King, T., Lai, J., Porreca, F. & Vanderah, T.W. (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J. Neurosci., 28, 11593-11602.
44. Gardell, L.R., Wang, R., Ehrenfels, C., Ossipov, M.H., Rossomando, A.J., Miller, S., Buckley, C., Cai, A.K., Tse, A., Foley, S.F., Gong, B., Walus, L., Carmillo, P., Worley, D., Huang, C., Engber, T., Pepinsky, B., Cate, R.L., Vanderah, T.W., Lai, J., Sah, D.W. & Porreca, F. (2003) Multiple actions of systemic artemin in experimental neuropathy. Nat. Med., 9, 1383-1389.
45. Gaskin, D.J. & Richard, P. (2012) The economic cost of pain in the United States. J. Pain, 13, 715-724.
46. Gazerani, P., Pedersen, N.S., Staahl, C., Drewes, A.M. & Arendt-Nielsen, L. (2009) Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain, 141, 60-69.
47. Giannantoni, A., Conte, A., Farfariello, V., Proietti, S., Vianello, A., Nardicchi, V., Santoni, G. & Amantini, C. (2013) Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity. Pharmacol. Res., 68, 118-124.
48. Goswami, C., Kuhn, J., Dina, O.A., Fernandez-Ballester, G., Levine, J.D., Ferrer-Montiel, A. & Hucho, T. (2011) Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway. J. Neurochem., 117, 995-1008.
49. Guindon, J. & Hohmann, A.G. (2009) The endocannabinoid system and pain. CNS Neurol. Disord.-Dr., 8, 403-421.
50. Gureje, O., Von Korff, M., Simon, G.E. & Gater, R. (1998) Persistent pain and well-being. JAMA-J. Am. Med. Assoc., 280, 147-151.
51. Ha, U.S., Park, E.Y. & Kim, J.C. (2011) Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity. Urology, 78, 721.e1-721.e6.
52. Hefti, F.F., Rosenthal, A., Walicke, P.A., Wyatt, S., Vergara, G., Shelton, D.L. & Davies, A.M. (2006) Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci., 27, 85-91.
53. von Hehn, C.A., Baron, R. & Woolf, C.J. (2012) Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron, 73, 638-652.
54. Heppenstall, P.A. & Lewin, G.R. (2000) Neurotrophins, nociceptors and pain. Curr. Opin. Anaesthesio., 13, 573-576.
55. Hermann, H., De Petrocellis, L., Bisogno, T., Schiano Moriello, A., Lutz, B. & Di Marzo, V. (2003) Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci., 60, 607-616.
56. Higgins, A., Yuan, S., Wang, Y. & Burrell, B.D. (2013) Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids. Mol. Pain, 9, 26.
57. Hill, R. (2011) Blocking the effects of NGF as a route to safe and effective pain relief-fact or fancy? Pain, 152, 2200-2201.
58. Hubbard, R.D., Martínez, J.J., Burdick, J.A. & Winkelstein, B.A. (2009) Controlled release of GDNF reduces nerve root-mediated behavioral hypersensitivity. J. Orthop. Res., 27, 120-127.
59. Hucho, T., Suckow, V., Joseph, E.K., Kuhn, J., Schmoranzer, J., Dina, O.A., Chen, X., Karst, M., Bernateck, M., Levine, J.D. & Ropers, H.H. (2012) Ca++/CaMKII switches nociceptor-sensitizing stimuli into desensitizing stimuli. J. Neurochem., 123, 589-601.
60. Indo, Y. (2001) Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum. Mutat., 18, 462-471.
61. Jankowski, M.P. & Koerber, H.R. (2010) Neurotrophic Factors and Nociceptor Sensitization. In Kruger, L., & Light, A.R. (Eds), Translational Pain Research: From Mouse to Man. CRC Press, FL, Chapter 2.
62. Jeske, N.A., Diogenes, A., Ruparel, N.B., Fehrenbacher, J.C., Henry, M., Akopian, A.N. & Hargreaves, K.M. (2008) A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain, 138, 604-616.
63. Ji, R.R., Samad, T.A., Jin, S.X., Schmoll, R. & Woolf, C.J. (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 36, 57-68.
64. Jimenez-Andrade, J.M., Mantyh, W.G., Bloom, A.P., Ferng, A.S., Geffre, C.P. & Mantyh, P.W. (2010) Bone cancer pain. Ann. N.Y. Acad. Sci., 1198, 173-181.
65. Jimenez-Andrade, J.M., Ghilardi, J.R., Castañeda-Corral, G., Kuskowski, M.A. & Mantyh, P.W. (2011) Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain, 152, 2564-2574.
66. Julius, D. & Nathans, J. (2012) Signaling by sensory receptors. Cold Spring Harb. Perspect. Biol., 4, a005991.
67. Khasabova, I.A., Holman, M., Morse, T., Burlakova, N., Coicou, L., Harding-Rose, C., Simone, D.A. & Seybold, V.S. (2013) Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiol. Dis., 58, 19-28.
68. Kim, Y.H., Back, S.K., Davies, A.J., Jeong, H., Jo, H.J., Chung, G., Na, H.S., Bae, Y.C., Kim, S.J., Kim, J.S., Jung, S.J. & Oh, S.B. (2012) TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron, 74, 640-647.
69. Klein, R. (1994) Role of neurotrophins in mouse neuronal development. FASEB J., 8, 738-744.
70. Kress, M. & Kuner, R. (2009) Mode of action of cannabinoids on nociceptive nerve endings. Exp. Brain Res., 196, 79-88.
71. Laínez, S., Valente, P., Ontoria-Oviedo, I., Estévez-Herrera, J., Camprubí-Robles, M., Ferrer-Montiel, A. & Planells-Cases, R. (2010) GABAA receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization. FASEB J., 24, 1958-1970.
72. Lauckner, J.E., Hille, B. & Mackie, K. (2005) The cannabinoid agonist WIN55, 212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. USA, 102, 19144-19149.
73. Lippoldt, E.K., Elmes, R.R., McCoy, D.D., Knowlton, W.M. & McKemy, D.D. (2013) Artemin, a glial cell line-derived neurotrophic factor family member, induces TRPM8-dependent cold pain. J. Neurosci., 33, 12543-12552.
74. Liu, B., Escalera, J., Balakrishna, S., Fan, L., Caceres, A.I., Robinson, E., Sui, A., McKay, M.C., McAlexander, M.A., Herrick, C.A. & Jordt, S.E. (2013) TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis. FASEB J. 27, 3549-3563.
75. Luo, W., Wickramasinghe, S.R., Savitt, J.M., Griffin, J.W., Dawson, T.M. & Ginty, D.D. (2007) A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron, 54, 739-754.
76. Maione, S., Costa, B. & Di Marzo, V. (2013) Endocannabinoids: a unique opportunity to develop multitarget analgesics. Pain, pii: S0304-3959(13)00118-8, doi: 10.1016/j.pain.2013.03.023 [Epub ahead of print].
77. Malin, S.A., Molliver, D.C., Koerber, H.R., Cornuet, P., Frye, R., Albers, K.M. & Davis, B.M. (2006) Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J. Neurosci., 26, 8588-8599.
78. Mantyh, P.W., Koltzenburg, M., Mendell, L.M., Tive, L. & Shelton, D.L. (2011) Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology, 115, 189-204.
79. Matsuura, Y., Iwakura, N., Ohtori, S., Suzuki, T., Kuniyoshi, K., Murakami, K., Hiwatari, R., Hashimoto, K., Okamoto, S., Shibayama, M., Kobayashi, T., Ogawa, Y., Sukegawa, K. & Takahashi, K. (2013) The effect of Anti-NGF receptor (p75 Neurotrophin Receptor) antibodies on nociceptive behavior and activation of spinal microglia in the rat brachial plexus avulsion model. Spine, 38, E332-E338.
80. Matthews, P.J., Aziz, Q., Facer, P., Davis, J.B., Thompson, D.G. & Anand, P. (2004) Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur. J. Gastroen. Hepat., 16, 897-902.
81. McCoy, E.S., Taylor-Blake, B. & Zylka, M.J. (2012) CGRPα-expressing sensory neurons respond to stimuli that evoke sensations of pain and itch. PLoS ONE, 7, e36355.
82. McDowell, T.S., Wang, Z.Y., Singh, R. & Bjorling, D. (2013) CB1 cannabinoid receptor agonist prevents NGF-induced sensitization of TRPV1 in sensory neurons. Neurosci. Lett., 551, 34-38.
83. McIlwrath, S.L., Lawson, J.J., Anderson, C.E., Albers, K.M. & Koerber, H.R. (2007) Overexpression of neurotrophin-3 enhances the mechanical response properties of slowly adapting type 1 afferents and myelinated nociceptors. Eur. J. Neurosci., 26, 1801-1812.
84. McKelvey, L., Shorten, G.D. & O'Keeffe, G.W. (2013) Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J. Neurochem., 124, 276-289.
85. Messeguer, A., Planells-Cases, R. & Ferrer-Montiel, A. (2006) Physiology and pharmacology of the vanilloid receptor. Curr. Neuropharmacol., 4, 1-15.
86. Moore, C., Cevikbas, F., Pasolli, H.A., Chen, Y., Kong, W., Kempkes, C., Parekh, P., Lee, S.H., Kontchou, N.A., Ye, I., Jokerst, N.M., Fuchs, E., Steinhoff, M. & Liedtke, W.B. (2013) UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc. Natl. Acad. Sci. USA, 110, E3225-E3234.
87. Morenilla-Palao, C., Planells-Cases, R., García-Sanz, N. & Ferrer-Montiel, A. (2004) Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J. Biol. Chem., 279, 25665-25672.
88. Murota, H., Izumi, M., Abd El-Latif, M.I., Nishioka, M., Terao, M., Tani, M., Matsui, S., Sano, S. & Katayama, I. (2012) Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis. J. Allergy Clin. Immun., 130, 671-682.
89. Nilius, B., Appendino, G. & Owsianik, G. (2012) The transient receptor potential channel TRPA1: from gene to pathophysiology. Pflugers Arch. Eur. J. Phy., 464, 425-458.
90. Nishigami, T., Osako, Y., Ikeuchi, M., Yuri, K. & Ushida, T. (2013) Development of heat hyperalgesia and changes of TRPV1 and NGF expression in rat dorsal root ganglion following joint immobilization. Physiol. Res., 62, 215-219.
91. Obata, K., Katsura, H., Mizushima, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Tokunaga, A., Tominaga, M. & Noguchi, K. (2005) TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest., 115, 2393-2401.
92. Orozco, O.E., Walus, L., Sah, D.W., Pepinsky, R.B. & Sanicola, M. (2001) GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Eur. J. Neurosci., 13, 2177-2182.
93. Osikowicz, M., Longo, G., Allard, S., Cuello, A.C. & Ribeiro-da-Silva, A. (2013) Inhibition of endogenous NGF degradation induces mechanical allodynia and thermal hyperalgesia in rats. Mol. Pain, 9, 37.
94. Pacher, P. & Kunos, G. (2013) Modulating the endocannabinoid system in human health and disease-successes and failures. FEBS J., 280, 1918-1943.
95. Pacher, P., Bátkai, S. & Kunos, G. (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 58, 389-462.
96. Paratcha, G. & Ledda, F. (2008) GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci., 31, 384-391.
97. Patwardhan, A.M., Jeske, N.A., Price, T.J., Gamper, N., Akopian, A.N. & Hargreaves, K.M. (2006) The cannabinoid WIN 55, 212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc. Natl. Acad. Sci. USA, 103, 11393-11398.
98. Pernía-Andrade, A.J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T.F., Watanabe, M., Filitz, J., Koppert, W., Schüttler, J., Ji, G., Neugebauer, V., Marsicano, G., Lutz, B., Vanegas, H. & Zeilhofer, H.U. (2009) Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science, 325, 760-764.
99. Petrosino, S. & Di Marzo, V. (2010) FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr. Opin. Investig. D., 11, 51-62.
100. Planells-Cases, R., Valente, P., Ferrer-Montiel, A., Qin, F. & Szallasi, A. (2011) Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. Adv. Exp. Med. Biol., 704, 491-515.
101. Ponsati, B., Carreño, C., Curto-Reyes, V., Valenzuela, B., Duart, M.J., Van den Nest, W., Cauli, O., Beltran, B., Fernandez, J., Borsini, F., Caprioli, A., Di, S.S., Veretchy, M., Baamonde, A., Menendez, L., Barros, F., de la Pena, P., Borges, R., Felipo, V., Planells-Cases, R. & Ferrer-Montiel, A. (2012) An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther., 341, 634-645.
102. Price, T.J. & Flores, C.M. (2007) Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J. Pain, 8, 263-272.
103. Price, T.J., Louria, M.D., Candelario-Soto, D., Dussor, G.O., Jeske, N.A., Patwardhan, A.M., Diogenes, A., Trott, A.A., Hargreaves, K.M. & Flores, C.M. (2005) Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion. BMC Neurosci., 6, 4.
104. Rani Sagar, D., Burston, J.J., Woodhams, S.G. & Chapman, V. (2012) Dynamic changes to the endocannabinoid system in models of chronic pain. Philos. T. Roy. Soc. B, 367, 3300-3311.
105. Ruparel, N.B., Patwardhan, A.M., Akopian, A.N. & Hargreaves, K.M. (2011) Desensitization of transient receptor potential ankyrin 1 (TRPA1) by the TRP vanilloid 1-selective cannabinoid arachidonoyl-2 chloroethanolamine. Mol. Pharmacol., 80, 117-123.
106. Sakai, A. & Suzuki, H. (2008) NCAM as a target for GDNF-induced analgesia in neuropathic pain. J. Nippon Med. Sch., 75, 136-137.
107. Sanz-Salvador, L., Andrés-Borderia, A., Ferrer-Montiel, A. & Planells-Cases, R. (2012) Agonist- and Ca2 + -dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. J. Biol. Chem., 287, 19462-19471.
108. Sariola, H. & Saarma, M. (2003) Novel functions and signalling pathways for GDNF. J. Cell Sci., 116, 3855-3862.
109. Schmidt, M., Dubin, A.E., Petrus, M.J., Earley, T.J. & Patapoutian, A. (2009) Nociceptive signals induce trafficking of TRPA1 to the plasma membrane. Neuron, 64, 498-509.
110. Schmutzler, B.S., Roy, S. & Hingtgen, C.M. (2009) Glial cell line-derived neurotrophic factor family ligands enhance capsaicin-stimulated release of calcitonin gene-related peptide from sensory neurons. Neuroscience, 161, 148-156.
111. Schmutzler, B.S., Roy, S., Pittman, S.K., Meadows, R.M. & Hingtgen, C.M. (2011) Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization. Mol. Pain, 7, 22.
112. Schreiber, A.K., Neufeld, M., Jesus, C.H. & Cunha, J.M. (2012) Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. Neuropharmacology, 63, 1286-1297.
113. Schwartz, E.S., La, J.H., Scheff, N.N., Davis, B.M., Albers, K.M. & Gebhart, G.F. (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J. Neurosci., 33, 5603-5611.
114. Sharkey, K.A., Cristino, L., Oland, L.D., Van Sickle, M.D., Starowicz, K., Pittman, Q.J., Guglielmotti, V., Davison, J.S. & Di Marzo, V. (2007) Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur. J. Neurosci., 25, 2773-2782.
115. Singh, T.A., Sántha, P. & Nagy, I. (2005) Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience, 136, 539-548.
116. Smith, T.H., Sim-Selley, L.J. & Selley, D.E. (2010) Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? Brit. J. Pharmacol., 160, 454-466.
117. Starowicz, K. & Przewlocka, B. (2012) Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system. Philos. T. Roy. Soc. B, 367, 3286-3299.
118. Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Di Marzo, V. & Przewlocka, B. (2012) Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. Neuropharmacology, 62, 1746-1755.
119. Starowicz, K., Makuch, W., Korostynski, M., Malek, N., Slezak, M., Zychowska, M., Petrosino, S., De Petrocellis, L., Cristino, L., Przewlocka, B. & Di, M.V. (2013) Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. PLoS ONE, 8, e60040.
120. Stein, A.T., Ufret-Vincenty, C.A., Hua, L., Santana, L.F. & Gordon, S.E. (2006) Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol., 128, 509-522.
121. Takasu, K., Sakai, A., Hanawa, H., Shimada, T. & Suzuki, H. (2011) Overexpression of GDNF in the uninjured DRG exerts analgesic effects on neuropathic pain following segmental spinal nerve ligation in mice. J. Pain, 12, 1130-1139.
122. Tender, G.C., Kaye, A.D., Li, Y.Y. & Cui, J.G. (2011) Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia. Neurosurgery, 68, 1048-1055.
123. Thornton, P., Hatcher, J.P., Robinson, I., Sargent, B., Franzén, B., Martino, G., Kitching, L., Glover, C.P., Anderson, D., Forsmo-Bruce, H., Low, C.P., Cusdin, F., Dosanjh, B., Williams, W., Steffen, A.C., Thompson, S., Eklund, M., Lloyd, C., Chessell, I. & Hughes, J. (2013) Artemin-GFRα3 interactions partially contribute to acute inflammatory hypersensitivity. Neurosci. Lett., 545, 23-28.
124. Turk, D.C. & Theodore, B.R. (2011) Epidemiology and economics of chronic and recurrent pain. In Lynch, M.E., Craig, K.D. & Peng, P.W.H. (Eds), Clinical Pain Management: A Practical Guide. Wiley-Blackwell, Oxford, UK, pp. 6-13.
125. Turk, D.C., Wilson, H.D. & Cahana, A. (2011) Treatment of chronic non-cancer pain. Lancet, 377, 2226-2235.
126. Uhelski, M.L., Cain, D.M., Harding-Rose, C. & Simone, D.A. (2013) The non-selective cannabinoid receptor agonist WIN 55, 212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain. Neuroscience, 247, 84-94.
127. Valdés-Sánchez, T., Kirstein, M., Pérez-Villalba, A., Vega, J.A. & Fariñas, I. (2010) BDNF is essentially required for the early postnatal survival of nociceptors. Dev. Biol., 339, 465-476.
128. Venkatachalam, K. & Montell, C. (2007) TRP channels. Annu. Rev. Biochem., 76, 387-417.
129. Walczak, J.S. & Cervero, F. (2011) Local activation of cannabinoid CB(1) receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol. Pain, 7, 31.
130. Walker, J.M. & Hohmann, A.G. (2005) Cannabinoid mechanisms of pain suppression. Handb. Exp. Pharmacol., 168, 509-554.
131. Wang, H. & Woolf, C.J. (2005) Pain TRPs. Neuron, 46, 9-12.
132. Wilson, S.R., Nelson, A.M., Batia, L., Morita, T., Estandian, D., Owens, D.M., Lumpkin, E.A. & Bautista, D.M. (2013) The ion channel TRPA1 is required for chronic itch. J. Neurosci., 33, 9283-9294.
133. Wilson-Gerwing, T.D. & Verge, V.M. (2006) Neurotrophin-3 attenuates galanin expression in the chronic constriction injury model of neuropathic pain. Neuroscience, 141, 2075-2085.
134. Wilson-Gerwing, T.D., Dmyterko, M.V., Zochodne, D.W., Johnston, J.M. & Verge, V.M. (2005) Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J. Neurosci., 25, 758-767.
135. Wilson-Gerwing, T.D., Stucky, C.L., McComb, G.W. & Verge, V.M. (2008) Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp. Neurol., 213, 303-314.
136. Woolf, C.J. & Ma, Q. (2007) Nociceptors-noxious stimulus detectors. Neuron, 55, 353-364.
137. Wu, D.F., Yang, L.Q., Goschke, A., Stumm, R., Brandenburg, L.O., Liang, Y.J., Hollt, V. & Koch, T. (2008) Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem., 104, 1132-1143.
138. Xiao, L., Cheng, J., Zhuang, Y., Qu, W., Muir, J., Liang, H. & Zhang, D. (2013) Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain. Pain Med., 14, 276-286.
139. Xu, Q., Zhang, M., Liu, J. & Li, W. (2013) Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release of GDNF. Ann. Clin. Lab. Sci., 43, 154-162.
140. Ye, Y., Dang, D., Zhang, J., Viet, C.T., Lam, D.K., Dolan, J.C., Gibbs, J.L. & Schmidt, B.L. (2011) Nerve growth factor links oral cancer progression, pain, and cachexia. Mol. Cancer Ther., 10, 1667-1676.
141. Yilmaz, Z., Renton, T., Yiangou, Y., Zakrzewska, J., Chessell, I.P., Bountra, C. & Anand, P. (2007) Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J. Clin. Neurosci., 14, 864-871.
142. Yoshida, N., Kobayashi, K., Yu, L., Wang, S., Na, R., Yamamoto, S., Noguchi, K. & Dai, Y. (2011) Inhibition of TRPA1 channel activity in sensory neurons by the glial cell line-derived neurotrophic factor family member, artemin. Mol. Pain, 7, 41.
143. Yudin, Y. & Rohacs, T. (2012) Regulation of TRPM8 channel activity. Mol. Cell. Endocrinol., 353, 68-74.
144. Zhang, X., Huang, J. & McNaughton, P.A. (2005) NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J., 24, 4211-4223.
145. Zheng, J. (2013) Molecular mechanism of TRP channels. Compr. Physiol., 3, 221-242.
146. Zhu, W. & Oxford, G.S. (2007) Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol. Cell. Neurosci., 34, 689-700.
147. Zogopoulos, P., Vasileiou, I., Patsouris, E. & Theocharis, S.E. (2013) The role of endocannabinoids in pain modulation. Fund. Clin. Pharmacol., 27, 64-80.